首页 | 官方网站   微博 | 高级检索  
     

老年2型糖尿病患者骨密度、胰岛素样生长因子-1的变化及其相关因素研究
引用本文:曾绍凡,吴艳,王毅,杨刚毅,李仁哲,朱晓荣,谭兴容,李颖.老年2型糖尿病患者骨密度、胰岛素样生长因子-1的变化及其相关因素研究[J].四川大学学报(医学版),2007,38(5):832-835.
作者姓名:曾绍凡  吴艳  王毅  杨刚毅  李仁哲  朱晓荣  谭兴容  李颖
作者单位:1. 四川省遂宁市人民医院,内分泌科,遂宁,629000
2. 重庆医科大学第二附属医院,内分泌科
3. 重庆医科大学附属北碚医院,内分泌科
4. 重庆医科大学检验系,临床生化教研室
摘    要:目的 探讨老年2型糖尿病患者骨密度变化及其与胰岛素样生长因子-1(IGF-1)、性激素及各种骨转换因子的相关关系. 方法采用单能定量CT(QCT)对53例2型糖尿病(T2DM)患者及40 例健康老年人进行脊柱骨密度(BMD)测定,并分析受试者的骨密度与体重指数(BMI)、腰臀比(WHR)、IGF-1、性激素、骨钙素(BGP)、骨特异性碱性磷酸酶(B-ALP)、抗酒石酸酸性磷酸酶-5b(TRACP-5b)等指标间的关系. 结果①老年2型糖尿病患者脊柱总BMD低于对照组(74.75±22.70) mg/cc vs(88.04±28.29) mg/cc,P<0.05].T2DM组血清IGF-1水平低于对照组(27.63±5.74) ng/mL vs (32.51±9.68) ng/mL, P<0.05].②相关性研究显示,T2DM组IGF-1水平与B-ALP呈正相关(r=0.46, P<0.01),两组受试者IGF-1水平与所测部位BMD均无相关. 结论老年2型糖尿病患者存在不同程度骨密度下降;IGF-1水平与骨密度的变化无相关性.

关 键 词:胰岛素样生长因子-1  单能定量CT  骨密度  糖尿病  2型  健康老年人  型糖尿病  患者  骨密度  胰岛素  样生长因子  变化  相关性研究  因素研究  Diabetes  Mellitus  Type  Elders  Level  Growth  Bone  Density  程度  存在  显示  水平  血清
修稿时间:2006-12-132007-03-28

Changes of Bone Density and Insulin-like Growth Factor-1 Level in Elders with Type 2 Diabetes Mellitus
ZENG Shao-fan,WU Yan,WANG Yi,YANG Gang-yi,LI Ren-ze,Zhu Xiao-rong,TAN Xing-rong,LI Ying.Changes of Bone Density and Insulin-like Growth Factor-1 Level in Elders with Type 2 Diabetes Mellitus[J].Journal of West China University of Medical Sciences,2007,38(5):832-835.
Authors:ZENG Shao-fan  WU Yan  WANG Yi  YANG Gang-yi  LI Ren-ze  Zhu Xiao-rong  TAN Xing-rong  LI Ying
Affiliation:Department of Endocrinology, the Second Hospital Affiliated to Chongqing University of Medical Science, Chongqing 400010, China
Abstract:OBJECTIVE: To investigate the changes of bone mineral density(BMD) and the relationship of BMD to serum Insulin-like growth factor-1 concentrations, body mass index (BMI), waist hip ratio (WHR), estradiol (E2), testosterone (T), biochemical markers of bone turnover as well as other factors in the elderly individuals with Type 2 diabetes mellitus (T2DM). METHODS: BMDs of spine were measured by quantitative CT for patients with T2DM (n=53) and health controls (n=40). The relationships of BMD related to serum Insulin-like growth factor-1 concentrations, BMI, WHR, E2, T, bone Gla'protein, bone alkaline phosphatase, tartrate resistant acid phosphatase 5b levels were also analyzed. RESULTS: The spine BMD values for the T2DM patients were significantly reduced when compared with controls (74.75 +/- 22.70) mg/cc vs. (88.04 +/- 28.29) mg/cc, P < 0.05], and the concentration of serum Insulin-like growth factor-1 in T2DM group was significantly lower than that in control (27.63 +/- 5.74) ng/mL vs. (32.51 +/- 9.68) ng/mL, P < 0.05]. The level of serum Insulin-like growth factor-1 was positive correlation to bone-specific alkaline phosphatase (B-ALP) in the T2DM patients (r = 0.46, P < 0.01). CONCLUSION: The spine BMD in elderly T2DM patients is lower than that in control group. The circulating serum Insulin-like growth factor-1 does not have a significant influence on bone mass in elderly T2DM patients.
Keywords:Insulin-like growth factor-1 Quantitative computed tomography Bone density Diabetes mellitus  type 2
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号